US Edition
Iovance appoints Corleen Roche as CFO - BioTuesdays
Summary by biotuesdays.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Iovance appoints Corleen Roche as CFO - BioTuesdays
Iovance Biotherapeutics (NASDAQ: IOVA) has announced the appointment of Corleen Roche as chief financial officer (CFO), effective August 6, 2025. Ms. Roche brings three decades of biotech and life sciences industry experience to the role, including executive financial leadership in publically traded companies. Prior to joining Iovance, she served as CFO of CG Oncology, a late-stage clinical biopharmaceutical company. Frederick G. Vogt, PhD, JD, …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
